Joel Gelfand
#133,971
Most Influential Person Now
Researcher
Joel Gelfand's AcademicInfluence.com Rankings
Joel Gelfandmedical Degrees
Medical
#2304
World Rank
#2719
Historical Rank
Epidemiology
#411
World Rank
#430
Historical Rank
Joel Gelfandphilosophy Degrees
Philosophy
#6848
World Rank
#9957
Historical Rank
Logic
#3946
World Rank
#5180
Historical Rank
Download Badge
Medical Philosophy
Joel Gelfand's Degrees
- Doctorate Medicine University of Pennsylvania
- PhD Epidemiology University of Pennsylvania
Why Is Joel Gelfand Influential?
(Suggest an Edit or Addition)According to Wikipedia, Joel M. Gelfand is an American dermatologist and epidemiologist at the University of Pennsylvania in Philadelphia, Pennsylvania. He currently serves as the James J. Leyden Professor in Clinical Investigation, the Vice Chair of Clinical Research, the director of the Psoriasis and Phototherapy Treatment Center, and the medical director of the Clinical Studies Unit in the Department of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. He studies systemic comorbidities of psoriasis and much of his research has centered on the connection between cardiovascular disease and psoriasis.
Joel Gelfand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risk of myocardial infarction in patients with psoriasis. (2006) (1401)
- Prevalence of cardiovascular risk factors in patients with psoriasis. (2006) (1016)
- The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. (2010) (658)
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. (2010) (618)
- Psoriasis and comorbid diseases: Epidemiology. (2017) (607)
- Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. (2005) (604)
- Epidemiology of psoriatic arthritis in the population of the United States. (2005) (570)
- Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. (2009) (540)
- The risk of mortality in patients with psoriasis: results from a population-based study. (2007) (523)
- Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. (2009) (504)
- Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. (2011) (493)
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. (2009) (481)
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. (2019) (437)
- National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. (2008) (429)
- Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. (2013) (422)
- Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom (2011) (415)
- The risk of stroke in patients with psoriasis. (2009) (395)
- Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study (2014) (370)
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa (2012) (366)
- Cause‐specific mortality in patients with severe psoriasis: a population‐based cohort study in the U.K. (2010) (359)
- Determinants of quality of life in patients with psoriasis: a study from the US population. (2004) (359)
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. (2010) (335)
- The risk of lymphoma in patients with psoriasis. (2006) (324)
- Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. (2018) (281)
- Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. (2011) (280)
- Psoriasis and metabolic disease: epidemiology and pathophysiology (2008) (275)
- The prevalence of psoriasis in African Americans: results from a population-based study. (2005) (273)
- Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. (2013) (257)
- Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. (2003) (250)
- Obesity and the risk of psoriatic arthritis: a population-based study (2012) (245)
- Increased risk for demyelinating diseases in patients with inflammatory bowel disease. (2005) (238)
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. (2019) (233)
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. (2011) (208)
- Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. (2011) (202)
- Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. (2019) (200)
- ATTRIBUTABLE RISK ESTIMATE OF SEVERE PSORIASIS ON MAJOR CARDIOVASCULAR EVENTS (2011) (187)
- AJC editor's consensus: psoriasis and coronary artery disease. (2008) (169)
- Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study (2015) (163)
- National Psoriasis Foundation clinical consensus on disease severity. (2007) (163)
- Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study (2013) (163)
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. (2015) (160)
- Consensus guidelines for the management of plaque psoriasis. (2012) (156)
- Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study (2019) (153)
- Impact of atopic dermatitis on health‐related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey (2017) (150)
- Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. (2014) (133)
- Psoriasis and comorbid diseases: Implications for management. (2017) (132)
- The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network. (2016) (131)
- From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis (2017) (131)
- Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. (2008) (129)
- Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. (2012) (129)
- Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. (2012) (127)
- Attributable risk estimate of severe psoriasis on major cardiovascular events. (2011) (123)
- Prevalence and treatment patterns of psoriatic arthritis in the UK. (2013) (121)
- From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. (2008) (120)
- Surrogate endpoints for the treatment of venous leg ulcers. (2002) (120)
- Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic (2020) (118)
- Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial (2018) (116)
- Validity of The Health Improvement Network (THIN) for the study of psoriasis (2011) (112)
- Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index. (2019) (111)
- Research gaps in psoriasis: opportunities for future studies. (2014) (108)
- Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study (2012) (107)
- Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults (2019) (106)
- Surrogate end points for the treatment of diabetic neuropathic foot ulcers. (2003) (103)
- Psoriasis in the U.S. Medicare population: prevalence, treatment, and factors associated with biologic use (2015) (101)
- Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study (2018) (100)
- Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. (2013) (100)
- Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease (2008) (95)
- Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors (2011) (93)
- Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. (2007) (92)
- Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009 (2013) (92)
- Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. (2016) (91)
- Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. (2019) (90)
- Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population‐Based Study (2017) (90)
- Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. (2018) (89)
- Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography (2017) (89)
- Metabolic Syndrome in Patients with Psoriatic Disease (2012) (88)
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies (2020) (88)
- GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. (2016) (88)
- Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study. (2020) (86)
- Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. (2015) (85)
- Patient satisfaction with treatments for moderate‐to‐severe plaque psoriasis in clinical practice (2014) (85)
- Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. (2012) (84)
- fJoint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. (2020) (82)
- Psoriasis and the risk of diabetes: A prospective population‐based cohort study (2018) (81)
- Methicillin‐Resistant Staphylococcus aureus Colonization in Children with Atopic Dermaitis (2008) (80)
- Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. (2018) (79)
- Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). (2012) (77)
- The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events (2017) (76)
- Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. (2014) (76)
- The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey (2018) (76)
- Pediatric Psoriasis Comorbidity Screening Guidelines (2017) (75)
- A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. (2009) (74)
- Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis (2016) (74)
- A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U trial). (2020) (73)
- Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study. (2017) (72)
- Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. (2009) (71)
- Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996–2009 (2013) (69)
- Use of complementary and alternative medicine among adults with skin disease: results from a national survey. (2009) (69)
- Pain is a common and burdensome symptom of atopic dermatitis in United States adults. (2019) (68)
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments (2021) (66)
- Psoriasis and cardiovascular risk: strength in numbers. (2010) (66)
- A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study. (2013) (65)
- Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study (2017) (64)
- Test Characteristics of High‐Resolution Ultrasound in the Preoperative Assessment of Margins of Basal Cell and Squamous Cell Carcinoma in Patients Undergoing Mohs Micrographic Surgery (2009) (64)
- Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. (2013) (64)
- OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results. (2015) (63)
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy (2019) (61)
- The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study (2017) (61)
- Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment. (2008) (60)
- Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. (2005) (60)
- Endothelial Cell‐, Platelet‐, and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors (2014) (59)
- Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10 (2019) (59)
- Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence (2015) (59)
- Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. (2014) (58)
- Prevalence and Treatment of Psoriasis in the United Kingdom (2005) (54)
- The impact of psoriasis on 10-year Framingham risk. (2012) (54)
- A Randomized Placebo Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate to Severe Plaque Psoriasis (VIP-S). (2020) (54)
- Is there truly a risk of lymphoma from biologic therapies? (2009) (54)
- Effectiveness of Online vs In-Person Care for Adults With Psoriasis (2018) (53)
- Update on the natural history and systemic treatment of psoriasis. (2008) (53)
- Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis (2019) (53)
- Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis (2018) (52)
- Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. (2019) (52)
- Medical Record Databases (2012) (51)
- Psoriasis and cardiovascular risk: strength in numbers, part II. (2011) (51)
- Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis (2017) (51)
- Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study. (2020) (51)
- Joint Aad-Npf Guidelines Of Care For The Management Of Psoriasis With Systemic Non-Biological Therapies. (2020) (48)
- Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study. (2018) (47)
- Development and Validation of an Algorithm to Accurately Identify Atopic Eczema Patients in Primary Care Electronic Health Records from the UK (2017) (47)
- HIV-positive patients in Botswana state that mobile teledermatology is an acceptable method for receiving dermatology care (2011) (47)
- Epidemiology of psoriasis (2006) (47)
- Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network (2014) (47)
- Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core (2020) (46)
- Unraveling Vascular Inflammation: From Immunology to Imaging. (2017) (46)
- Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom. (2018) (46)
- Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3 (2011) (45)
- Health Utility Scores of Atopic Dermatitis in US Adults. (2019) (45)
- The epidemiology of sunburn in the US population in 2003. (2006) (43)
- Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis: An Observational Cohort Study (2018) (43)
- National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 (2020) (43)
- Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. (2012) (42)
- Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study (2020) (42)
- Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors (2014) (41)
- The psychometric properties of the psoriasis disability index in United States patients. (2005) (40)
- Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential (2005) (40)
- The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic (2020) (40)
- Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses. (2013) (40)
- High Prevalence of Aquagenic Wrinkling of the Palms in Patients with Cystic Fibrosis and Association with Measurable Increases in Transepidermal Water Loss (2012) (39)
- Familial Basaloid Follicular Hamartoma: Lesional Characterization and Review of the Literature (2003) (39)
- High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response. (2011) (38)
- The epidemiology of atopic dermatitis. (2003) (38)
- Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. (2018) (38)
- Distribution of atopic dermatitis lesions in United States adults (2019) (37)
- Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis (2009) (37)
- Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. (2018) (35)
- Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults. (2018) (34)
- Atopic Dermatitis in US Adults: From Population to Health Care Utilization. (2019) (34)
- Assessing long-term drug safety: lessons (re) learned from raptiva. (2010) (34)
- Seeing red: flushing out instigators of niacin-associated skin toxicity. (2010) (34)
- OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis. (2013) (34)
- Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. (2012) (32)
- Clinical factors associated with subclinical spread of in situ melanoma (2017) (31)
- Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial. (2019) (31)
- Recommendations for phototherapy during the COVID-19 pandemic (2020) (31)
- Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis. (2013) (31)
- Prospective Cohort Study Investigating Changes in Body Image, Quality of Life, and Self-Esteem Following Minimally Invasive Cosmetic Procedures (2018) (30)
- Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students. (2019) (30)
- Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. (2010) (29)
- Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12. (2007) (29)
- Stimulated rat mast cells generate histamine-releasing peptide from albumin (1993) (29)
- Clinical and pathologic factors associated with subclinical spread of invasive melanoma (2017) (28)
- Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. (2016) (28)
- Update on the epidemiology and systemic treatment of psoriasis (2007) (28)
- Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment. (2019) (27)
- Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis. (2013) (27)
- Srcasm Corrects Fyn-induced Epidermal Hyperplasia by Kinase Down-regulation* (2007) (27)
- Variations in risk of asthma and seasonal allergies between early‐ and late‐onset pediatric atopic dermatitis: A cohort study (2017) (27)
- Self-reported depression in psoriasis is associated with subclinical vascular diseases. (2016) (26)
- Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study. (2017) (25)
- Psoriasis, Type 2 Diabetes Mellitus, and Obesity: Weighing the Evidence. (2016) (25)
- Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome. (2005) (25)
- Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. (2014) (24)
- Reliability and validity of mobile teledermatology in human immunodeficiency virus-positive patients in Botswana: a pilot study. (2014) (24)
- Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining (2016) (24)
- Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. (1998) (24)
- The UK General Practice Research Database (2007) (23)
- Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study. (2017) (23)
- Faculty Opinions recommendation of Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. (2007) (22)
- Effect of Wax Epilation Before Hair Removal With a Long‐Pulsed Alexandrite Laser: A Pilot Study (2003) (22)
- Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study. (2021) (22)
- Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting (2013) (22)
- A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers. (2009) (21)
- Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI‐R score, in two independent populations (2019) (21)
- Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis. (2004) (20)
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. (2019) (20)
- Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults. (2019) (20)
- Diet and weight loss as a treatment for psoriasis. (2010) (20)
- Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply. (2013) (19)
- Spectrum of virucidal activity from ultraviolet to infrared radiation (2020) (19)
- Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response – results of a phase II regimen‐finding trial (2016) (18)
- Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma (2011) (18)
- The risk of IgA nephropathy and glomerular disease in patients with psoriasis: a population‐based cohort study (2017) (18)
- Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations. (2008) (17)
- The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic (2020) (17)
- A call for health policy education in the medical school curriculum. (1995) (17)
- Mental health impairment among children with atopic dermatitis: a U.S. population-based cross-sectional study of the 2013-2017 National Health Interview Survey. (2020) (17)
- Metabolic Syndrome and its Factors are Associated with Non-Calcified Coronary Plaque Burden in Psoriasis: An Observational Cohort Study. (2020) (16)
- Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population‐based study in the United Kingdom (2017) (16)
- Psoriasis: a novel risk factor for type 2 diabetes. (2018) (15)
- Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort (2019) (15)
- Adverse cutaneous reactions to guggulipid. (2005) (15)
- Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality?: A critical question that we are only just beginning to answer. (2018) (15)
- Curcuminoids activate p38 MAP kinases and promote UVB‐dependent signalling in keratinocytes (2010) (15)
- Psoriasis and psoriatic arthritis: a public health agenda. (2013) (15)
- Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States. (2019) (14)
- Prevalence of the Metabolic Syndrome in Psoriasis (2015) (14)
- High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis (2017) (14)
- High density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction (2013) (13)
- Impact of biologic agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: a systematic review and meta-analysis of randomized placebo-controlled trials. (2021) (13)
- Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time (2020) (13)
- Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis. (2019) (13)
- Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population‐based cohort study * (2021) (13)
- Does biologic therapy impact the development of PsA among patients with psoriasis? (2021) (13)
- Atopic dermatitis disease control and age: A cohort study. (2015) (12)
- Examples of Automated Databases (2013) (12)
- Association of neutrophil-to-lymphocyte ratio with non-calcified coronary artery burden in psoriasis: Findings from an observational cohort study. (2020) (12)
- Validation and interpretation of short form 12 and comparison with dermatology life quality index in atopic dermatitis in adults. (2019) (12)
- Health care utilization for psoriasis in the United States differs by race: An analysis of the 2001‐2013 Medical Expenditure Panel Surveys (2018) (11)
- Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis. (2015) (11)
- Machine Learning Applications in the Evaluation and Management of Psoriasis: A Systematic Review (2020) (11)
- Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic (2020) (11)
- Application of Machine Learning to Determine Top Predictors of Non-calcified Coronary Burden in Psoriasis: an Observational Cohort Study. (2019) (11)
- Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis. (2020) (11)
- Long-term treatment for severe psoriasis: we're halfway there, with a long way to go. (2007) (11)
- The role of topical therapy for patients with extensive psoriasis. (2007) (10)
- Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis. (2021) (10)
- Retrospective Analysis of Beta-Blocker Instituted for Treatment of Hemangiomas (RABBIT Study) (2014) (9)
- Cells of myeloid origin partly mediate the association between psoriasis severity and coronary plaque. (2020) (9)
- Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study (2019) (9)
- Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease. (2022) (9)
- Use of primary care services among patients with chronic skin disease seen by dermatologists (2020) (9)
- Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. (2015) (9)
- Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies (2021) (8)
- National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference (2017) (8)
- Outcomes Research in Psoriasis and Psoriatic Arthritis Using Large Databases and Research Networks: A Report from the GRAPPA 2013 Annual Meeting (2014) (8)
- Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis (2020) (8)
- Association between atopic dermatitis and learning disability in children. (2020) (8)
- Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology. (2018) (8)
- Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. (2021) (8)
- Responsiveness of the EuroQol 5‐Dimension 3‐Level instrument, Dermatology Life Quality Index (DLQI) and DLQI‐Relevant for patients with psoriasis in the U.S.A. (2019) (8)
- Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study. (2021) (8)
- Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument. (2019) (7)
- Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images. (2015) (7)
- Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences (2018) (7)
- Behind the Numbers: Number Needed to Screen (2011) (7)
- Patient-Reported Outcomes of Adalimumab, Phototherapy, and Placebo in the Vascular Inflammation in Psoriasis Trial: A Randomized Controlled Study. (2019) (7)
- Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database (2019) (7)
- Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases. (2019) (7)
- Skin Cancer Management: A Practical Approach (2010) (6)
- Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII. (2017) (6)
- Psoriasis and Comorbid Diseases Part II. Implications for Management (2018) (6)
- Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis (2020) (6)
- Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States. (2021) (6)
- Opioid Prescribing in Adults with and without Psoriasis. (2020) (6)
- How similar are the treatment responses to biosimilars in patients with psoriasis? A systematic review of statistical margins in comparative clinical trials (2017) (6)
- Clinical Research after COVID-19: Embracing a New Normal (2020) (6)
- Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis (2017) (6)
- Srcasm overexpression in psoriasis‐insights into pathogenesis (2007) (5)
- Exploring Priority Research Areas in Psoriasis and Psoriatic Arthritis from Dermatologists’ Perspective: A Report from the GRAPPA 2011 Annual Meeting (2012) (5)
- CD8+ lymphoma in a patient with human immunodeficiency virus. (2005) (5)
- Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics[S] (2017) (5)
- Relationship between chronic stress-related neural activity, physiological dysregulation and coronary artery disease in psoriasis: Findings from a longitudinal observational cohort study. (2020) (5)
- Dermatologist response rates to a mailed questionnaire: a randomized trial of monetary incentives. (2012) (5)
- Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis. (2012) (5)
- 393 A trial to determine the effect of psoriasis treatment (adalimumab, phototherapy, and placebo) on cardiometabolic disease: The vascular inflammation in psoriasis (VIP) trial (2018) (5)
- Counterpoint: A tale of two meta-analyses revisited. (2014) (4)
- Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII (2016) (4)
- Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network-Patient Characteristics and Dietary Counseling. (2020) (4)
- Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism. (2021) (4)
- Anticipated and Perceived Stigma Among Patients With Psoriasis (2020) (4)
- Underperformance of clinical risk scores in identifying imaging-based high cardiovascular risk in psoriasis: results from two observational cohorts. (2020) (4)
- Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab (2015) (4)
- Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts (2018) (4)
- Lack of association of biologic therapy for psoriasis with psychiatric illness: An electronic medical records cohort study (2019) (4)
- OBSERVE-5, an Observational Post-Marketing Safety Surveillance Registry of Etanercept for the Treatment of Psoriasis: A Model for Studying New Psoriasis Therapies (2010) (4)
- Clinically significant therapeutic interactions for the practicing dermatologist. (1999) (4)
- Reliability and validity of a photographic method for measuring facial hair density in men. (2011) (3)
- Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors (2012) (3)
- Treat-to-target and Improving Outcomes in Psoriasis: A Report from the GRAPPA 2014 Annual Meeting (2015) (3)
- Treatment of bullous pemphigoid with topical corticosteroids: review of a randomized controlled trial. (2002) (3)
- Engaging the Patient's Perspective in Clinical Trials Research. (2019) (3)
- Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis. (2006) (3)
- 191 Increased risk of serious infection among patients with psoriasis: A population-based cohort study in the United Kingdom (2016) (3)
- Biologic therapy prescribing is not associated with psychiatric illness: an electronic medical records cohort study. (2019) (3)
- Nodular fasciitis. (2001) (3)
- TREATMENT WITH BIOLOGIC THERAPY IN PSORIASIS IS ASSOCIATED WITH A REDUCTION IN CORONARY ARTERY INFLAMMATION, ASSESSED BY PERIVASCULAR FAT ATTENUATION INDEX (2019) (3)
- Aortic valve stenosis: a new cardiovascular comorbidity of psoriasis? (2015) (2)
- The Smoking Paradox in the Development of Psoriatic Arthritis among Psoriasis Patients – A Population-Based Study (2017) (2)
- Eruption of human immunodeficiency virus seroconversion (1998) (2)
- Subclinical Liver Disease is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies. (2021) (2)
- FRI0355 IMPACT OF BIOLOGIC THERAPY ON THE INCIDENCE OF PSA AMONG PATIENTS WITH PSORIASIS (2020) (2)
- IMPROVEMENT IN LARGE DENSITY HDL PARTICLE NUMBER BY NMR IS ASSOCIATED WITH IMPROVEMENT IN VASCULAR INFLAMMATION BY 18-FDG PET/CT AT ONE-YEAR IN PSORIASIS (2018) (2)
- Psoriasis and Risk of Myocardial Infarction—Reply (2007) (2)
- Examples of Existing Automated Databases (2013) (2)
- Impaired Coronary Blood Flow in Patients with Psoriasis: Findings from an Observational Cohort Study. (2020) (2)
- Comparative Effectiveness Research: What It Is and How to Assess Its Quality (2014) (2)
- Biologic Adherence among Psoriasis Patients in the us Medicare Population (2015) (2)
- Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients (Journal of Investigative Dermatology (2007) 127, (2315-2322) DOI: 10.1038/sj.jid.5700875) (2008) (2)
- An asymptomatic penile plaque with regional lymphadenopathy. (1999) (2)
- Counselling patients for return to work on immunosuppression: practices of Canadian specialists during the COVID-19 pandemic. (2021) (2)
- Validity of diagnostic codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network (2017) (2)
- POS1063 RHEUMATOLOGIST AND PATIENT PERSPECTIVES ON IMPLEMENTING CARDIOVASCULAR RISK PREVENTION IN THE MANAGEMENT OF PSORIASIS: A QUALITATIVE STUDY (2021) (2)
- Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system. (2020) (2)
- Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. (2019) (2)
- Treatment utilization and drug survival of systemic medications among commercially insured children with psoriasis (2021) (2)
- Responsiveness of the EQ-5D-3L, DLQI, and DLQI-R for Patients With Psoriasis in the United States. (2019) (2)
- A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men. (2012) (2)
- Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial. (2022) (2)
- Measurement properties of Hospital Anxiety and Depression Scale used in atopic dermatitis in adults: 391 (2019) (1)
- CD30+, CD8+, CD4- Cutaneous Lymphoma with Sarcoidosis (2001) (1)
- Association of S100A8/A9 with lipid-rich necrotic core and treatment with biologic therapy in patients with psoriasis: results from an observational cohort study. (2022) (1)
- Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment? (2020) (1)
- Pseudofolliculitis of the Beard (2004) (1)
- Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting. (2015) (1)
- 282 Moderate to severe atopic dermatitis is associated with allergic, autoimmune and cardiovascular comorbidities in US adults (2018) (1)
- ELEVATED ENDOTHELIAL CELL, PLATELET AND T-CELL MICROPARTICLES IN PSORIASIS MAY PROVIDE NOVEL LINK TO ATHEROSCLEROSIS (2012) (1)
- 2018 Eastern Regional Meeting (2018) (1)
- 271 Psoriasis patients perceptions of therapies differ by race (2018) (1)
- OP0311 Physical Trauma is Associated with the Onset of Psoriatic Arthritis Among Psoriasis Patients (2015) (1)
- Iconography : Psoriasis and the risk of diabetes: A prospective population-based cohort study (2018) (1)
- Mental health in adult AD (2019) (1)
- Response to ‘Kidney disease in moderate‐to‐severe psoriasis: a critical appraisal’ (2016) (1)
- 969 Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease (2008) (1)
- Atopic dermatitis and risk of major neuropsychiatric disorders in children: A population‐based cohort study (2022) (1)
- Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by. (2016) (1)
- 197 Sociodemographic characteristics predict persistent atopic dermatitis disease activity into early adulthood: A longitudinal cohort study (2016) (1)
- A COMPARISON OF VASCULAR INFLAMMATION IN RHEUMATOID ARTHRITIS, PSORIASIS AND HEALTHY CONTROLS BY FDG-PET/CT: A PILOT STUDY (2013) (1)
- Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living With Psoriatic Disease (2022) (1)
- Addressing Comorbid Diseases in Patients with Moderate-to-Severe Psoriasis (2013) (0)
- Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism (2021) (0)
- Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study (2022) (0)
- Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?” (2020) (0)
- Response to Gau, Shuo-Yan's "Methotrexate Use and Liver Outcomes in Psoriasis and Rheumatoid Arthritis Patients -a Commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study". (2021) (0)
- 515 The LITE study baseline characteristics for fitzpatrick skin type group 1/2 (2023) (0)
- Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis Council (2022) (0)
- Abstract 588: Glyc-A, a Novel Inflammatory Biomarker, is Associated With Total and Non-Calcified Coronary Plaque Burden Beyond Traditional Cardiovascular Risk Factors (2016) (0)
- Faculty Opinions recommendation of Serious infection risk in children with psoriasis on systemic treatment: a propensity score matched population-based study. (2020) (0)
- 124 The risk of liver disease in psoriasis patients: A population-based cohort (2016) (0)
- CIRCULATING LEVELS OF INTERFERON-γ AND TUMOR NECROSIS FACTOR-α ARE ASSOCIATED WITH LIPID-RICH CORONARY PLAQUE IN PSORIASIS (2019) (0)
- The use of FDG-PET/CT to evaluate vascular inflammation in inflammatory diseases compared to healthy controls: A pilot study (2013) (0)
- AORTIC DISTENSIBILITY BY MAGNETIC RESONANCE IMAGING INVERSELY ASSOCIATES WITH NON-CALCIFIED CORONARY PLAQUE BURDEN BY CORONARY CT ANGIOGRAPHY IN PSORIASIS (2019) (0)
- The pitfalls of a purely clinical definition of nephrogenic systemic fibrosis: comment on the article by Todd et al. (2008) (0)
- Abstract 16374: Low Density Granulocytes Associate With Non-Calcified Coronary Plaque in Psoriasis (2017) (0)
- 272 Adults with psoriasis have lower influenza vaccination rates than adults with other chronic illnesses (2018) (0)
- Pharmacovigilance (2021) (0)
- Is It Prime Time for Statin Therapy in Psoriasis? (2022) (0)
- SOLUBLE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 IS ASSOCIATED WITH SUBCLINICAL CORONARY ARTERY DISEASES IN PSORIASIS (2019) (0)
- 251 Dermatologist preferences regarding implementation strategies to improve statin use among patients with psoriasis (2021) (0)
- Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT) (2014) (0)
- AORTIC VASCULAR INFLAMMATION BY 18-FDG PET/CT ASSOCIATES WITH HIGH-RISK CORONARY PLAQUES IN YOUNG PSORIASIS PATIENTS (2017) (0)
- In response to: “Reply to research letter” (2020) (0)
- Building Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts. (2018) (0)
- 162 The impact of psoriasis body surface area on mortality: A prospective population-based cohort study (2017) (0)
- Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the (2012) (0)
- OP0115 GENERAL AND SEX-SPECIFIC PREDICTORS OF PSA AMONG PATIENTS WITH PSORIASIS (2019) (0)
- Distribution of Early Career Research Funding by Specialty from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2023) (0)
- Commentary (1999) (0)
- Autoimmune diseases and cardiovascular risk. (2022) (0)
- 185 Fracture risk in adult and pediatric patients with atopic dermatitis -a population-based cohort study (2022) (0)
- Abstract 12190: The Risk of Myocardial Infarction in Patients with Psoriasis: Results from a Large Population-Based Cohort Study (2011) (0)
- Health Care Costs Associated with Different Biologic Treatment Patterns Among U.S. Medicare Patients with Psoriasis (2018) (0)
- 591 Stigma of psoriasis: Patient perspectives (2019) (0)
- 245 Validation and interpretation of short form 12 and comparison with dermatology life quality index in adult atopic dermatitis (2019) (0)
- 321 Regional differences in cardiovascular risk factor screening for patients with psoriasis by dermatology providers (2022) (0)
- 207 Identifying the margin of difference in response rate for active comparator psoriasis trials: A systematic review (2017) (0)
- Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis (2018) (0)
- Faculty Opinions recommendation of Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. (2020) (0)
- The patient perspective on vaccine uptake in adults with psoriasis and eczema (2022) (0)
- Faculty Opinions recommendation of Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. (2017) (0)
- Clinically Relevant Vulnerabilities of Deep Machine Learning Systems for Skin Cancer Diagnosis (2021) (0)
- Efficacy and safety of adalimumab treatment in psoriasis with psoriatic arthritis: Result from post-marketing surveillance in Japan (2010) (0)
- Dr. Joel M. Gelfand (2020) (0)
- Sex Differences in Subclinical Coronary Atherosclerosis in Psoriasis by Coronary Computed Tomography Angiography. (2021) (0)
- Abstract 12996: Atherogenic Lipoprotein Particle Size and Number Despite Normal Lipid Profiles in Psoriasis (2011) (0)
- Psoriasis is associated with increased aortic inflammation as measured on FDG-PET/CT - A novel observation (2011) (0)
- Unraveling Vascular Inflammation (0)
- HIGH-SENSITIVITY TROPONIN IS ASSOCIATED WITH HIGH-RISK CORONARY PLAQUE IN PSORIASIS (2019) (0)
- Faculty Opinions recommendation of Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. (2008) (0)
- Patient-reported Outcomes: Association with Clinical Response to Psoriasis Therapies (2016) (0)
- 188 Predictors of healthcare utilization in US adults with atopic dermatitis (2019) (0)
- Supplementary Table E-1-3 (2020) (0)
- 211 Adults with psoriasis receive more opioid prescriptions than adults without psoriasis (2019) (0)
- Assessment and quantification of psoriasis disease activity using FDG-PET/CT: A novel concept (2013) (0)
- Supplementary Tables and Methods (2020) (0)
- FRI0458 OBJECTIVE MEASURES OF PSORIASIS SEVERITY AND THE RISK FOR PSA: RESULTS FROM THE INCIDENT HEALTH OUTCOMES AND PSORIASIS EVENTS PROSPECTIVE COHORT STUDY (2019) (0)
- Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States. (2023) (0)
- Faculty Opinions recommendation of First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. (2018) (0)
- 450 Risk of inflammatory bowel disease in patients with atopic dermatitis- a population based cohort study (2020) (0)
- 32824 Factors associated with treatment satisfaction in atopic dermatitis: A cross-sectional, population-based study examining patient and physician perspectives (2022) (0)
- Behind the Numbers: Odds Ratio vs. Relative Risk (2012) (0)
- 546 Pain is a distinct and burdensome symptom of atopic dermatitis in US adults (2019) (0)
- IMPROVEMENT IN SKIN DISEASE SEVERITY IS ASSOCIATED WITH REDUCED PROGRESSION OF AORTIC WALL THICKNESS IN PATIENTS WITH PSORIASIS (2018) (0)
- Abstract 11998: Treatment of Psoriasis With Biologic Therapy is Associated With Regression of Coronary Artery Plaque Necrotic Core and Positive Remodeling: Results From a Prospective, Observational Pilot Study (2019) (0)
- Increased risk of opportunistic infections among patients with moderate-to-severe psoriasis: a population-based cohort study in the United Kingdom. (2016) (0)
- CORONARY PLAQUE BURDEN IS ASSOCIATED WITH CHOLESTEROL EFFLUX CAPACITY PARTIALLY MEDIATED BY THE HEMATOPOIETIC SYSTEM IN PSORIASIS (2019) (0)
- APPLICATION OF MACHINE LEARNING TO DETERMINE TOP PREDICTORS OF NON-CALCIFIED CORONARY PLAQUE BURDEN IN PSORIASIS (2019) (0)
- 276 Risk of headache and migraine in patients with atopic dermatitis- A population based cohort study (2021) (0)
- Patients with adult- and late childhood-onset atopic dermatitis report a higher burden of disease severity than patients with early childhood-onset atopic dermatitis. (2018) (0)
- Abstract 868: Prevalence, Underdiagnosis, and Undertreatment of Cardiovascular Risk Factors in Patients With Moderate-to-Severe Psoriasis (2009) (0)
- Abstract P041: Adipose Inflammation as Assessed by Adipose FDG Uptake is Associated With Aortic Vascular Inflammation in Psoriasis (2019) (0)
- 266 Risk of opportunistic, viral, and hospitalized infections in atopic dermatitis (2021) (0)
- Gelfand and Abuabara Teaching Dermatology Using 3-dimensional Virtual Reality (0)
- 234 Atopic dermatitis is associated with distinct phenotypes in US adults (2019) (0)
- 538 The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo (2019) (0)
- 32607 Risk of cardiovascular events and all cause mortality in patients with atopic dermatitis: A population-based cohort study (2022) (0)
- Author index (2005) (0)
- A Tale of Two Meta-Analyses - Revisited (2015) (0)
- Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians (2023) (0)
- 539 Severity strata for POEM, PO-SCORAD and DLQI in a population-based sample of US adults with atopic dermatitis (2018) (0)
- Top-Accessed Article: Psoriasis Associated With Hyperleptinemia (2010) (0)
- Optimizing Therapy for Patients With Psoriasis (2015) (0)
- Comparing Online Care with In-Person Care for Patients With Psoriasis (2020) (0)
- Oral Curcuminoid C3 Complex® in the Treatment of Moderate to Severe Psoriasis Vulgaris: A Prospective Clinical Trial (2014) (0)
- 458 Effects of text message reminders on data collection in a pragmatic study (2020) (0)
- Prevalence of clinically significant incidental findings by whole-body FDG-PET/CT scanning in moderate-to-severepsoriasis patients participating in clinical trials (2019) (0)
- 382 A novel assessment of cardiovascular health in people with psoriasis in the US: a cross-sectional study (2023) (0)
- Delays in Intensification are Common in Adults with Acute Lymphoblastic Leukemia (ALL), are Associated with Decreased Survival in Allogeneic Hematopoietic Cell Transplant (HCT) Patients (2015) (0)
- Response to: “Successful implementation of phototherapy guidelines during the COVID-19 pandemic” (2021) (0)
- Avoiding palmar ambiguity in the PREPI: a handprint is approximately 1% body surface area – Reply (2011) (0)
- Abstract 15881: GlycA Predicts Vascular Inflammation by 18-FDG PET/CT Beyond hsCRP in Psoriasis at Baseline and 1-year Follow-up (2016) (0)
- 139 The risk of lymphoma in patients with psoriasis: A cohort study in the United Kingdom (2016) (0)
- Cardiovascular Health in People with Psoriasis: a population-based study in the United States. (2023) (0)
- 390 Atopic dermatitis and risk of major neuropsychiatric disorders: A population-based cohort study (2020) (0)
- 193 Risk of venous thromboembolism is increased among patients with psoriasis (2016) (0)
- 514 Using design thinking to develop a decision aid for patients with psoriatic disease (2020) (0)
- Adherence to Treatment: Still the Forgotten Variable—Reply (2010) (0)
- Identifying Top Predictors of Change in Noncalcified Coronary Burden in Psoriasis by Machine Learning Over 1-Year (2021) (0)
- 551 The stigma of psoriasis: Public and healthcare professional perceptions (2018) (0)
- The JID: A Scientific Home for Innovative, Rigorously Conducted, Clinical, and Epidemiologic Research in Dermatology from Around the World. (2022) (0)
- Expanding the Global Perspective on Psoriasis. (2023) (0)
- Abstract P363: Visceral, but Not Subcutaneous Adiposity by Computed Tomography is Associated With Increased Aortic Wall Thickness in Psoriasis Patients (2018) (0)
- Reply to: "Statistical and methodological issues". (2017) (0)
- Prescribing Patterns Associated with Biologic Therapies for Psoriasis from a U.S. Medical Records Database (2019) (0)
- Outcomes of Comorbidities with Biologic and Systemic Agents (2018) (0)
- American Academy of Dermatology/Physician Consortium for Performance Improvement® FOR CONSORTIUM VOTE Melanoma Physician Performance Measurement Set (2006) (0)
- 668 Prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis (CP3) study: Preliminary results (2023) (0)
- 263 Atopic dermatitis and the risk of developing rheumatoid arthritis - A population-based cohort study (2021) (0)
- 389 Impact of the COVID19 pandemic on the execution of real world, pragmatic trials: The LITE study experience (2022) (0)
- The Relationship between Circulating Apolipoprotein A-1 and Atherosclerosis Initiation and Progression in Psoriasis. (2023) (0)
- 248 Patient and physician perspectives in atopic dermatitis: a population-based cross-sectional study (2019) (0)
- Measuring Physical Stigmata of Niacin-Associated Skin Toxicity by Colorimetry , White-Light Spectroscopy , Laser Doppler Flowmetry , and Thermometry in Combination with Symptom Perception Scoring : Methods to Aid Development of Niacin Mimetics (2017) (0)
- 175 Impact of childhood atopic dermatitis on cognition and achievement (2022) (0)
- 212 Concerns about psoriasis differ by race: implications for patient-centered goal-setting and counseling (2019) (0)
- Errata (1975) (0)
- MÉTHODES DE TRAITEMENT DU VITILIGO À L'AIDE D'ANTICORPS DE L'INTERLEUKINE-17 (IL -17) (2017) (0)
- Abstract 14382: Psoriasis is Associated with Impaired HDL Efflux Despite Normal HDL Levels Compared to Controls (2011) (0)
- PET-PASI score: Utility of FDG-PET/CT in Psoriasis (2020) (0)
- Outpatient Management of COVID-19: A Primer for the Dermatologist (2022) (0)
- Abstract 15887: Treatment of Skin Inflammation is Associated With a Reduction in High Risk Coronary Plaque Progression at One-Year Follow-up (2017) (0)
- Abstract 1640: Patients With Severe Psoriasis and No History of Cardiovascular Disease Are at Increased Risk of Cardiovascular Mortality (2009) (0)
- Faculty Opinions recommendation of Smoking and the risk of psoriasis in women: Nurses' Health Study II. (2007) (0)
This paper list is powered by the following services:
Other Resources About Joel Gelfand
What Schools Are Affiliated With Joel Gelfand?
Joel Gelfand is affiliated with the following schools:
